Although researchers in a multicenter international study previously evaluated the performance of urinary TIMP-2 with a larger population, the present study includes the important strength of comparing urinary TIMP-2 with other biomarkers that are not limited to AKI and can be used to monitor different mechanisms of diseases. This evidence concerns the gene TIMP2 and acute kidney injury.